Evidence map›Paper›PMID 42095730›Full record

ArticleJournal of the American Geriatrics Society2026

Measuring Medication Related Harm: Proposed Guidance for Adverse Drug Event Adjudication to Harmonize Outcomes in Deprescribing Research.

Sydney B Ross, Émilie Bortolussi-Courval, Zuzana Juhásová, Daniala L Weir, Allison Goodwin Wilson, Todd C Lee, Emily G McDonald, Marnie Goodwin Wilson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Geriatrics Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sydney B RossFaculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
Émilie Bortolussi-CourvalFaculty of Medicine and Health Sciences, Université de Sherbrooke, Longueuil, Quebec, Canada.ORCID https://orcid.org/0000-0002-4926-5195
Zuzana JuhásováDepartment of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.ORCID https://orcid.org/0000-0002-0050-5418
Daniala L WeirDivision of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Allison Goodwin WilsonFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Todd C LeeCentre for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-2267-4239
Emily G McDonaldFaculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-0783-0624
Marnie Goodwin WilsonDivision of General Internal Medicine and Division of Critical Care Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0001-5180-0831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjudicationadverse drug eventsmedication related harmMedSaferpolypharmacy

Identifiers

PMID42095730
PMCPMC13496365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.